Medicine & TechnologyA new Malaysian study that tested Ivermectin drug on 490 vulnerable patients over 50 years old showed no significant difference in preventing severe illness, casting doubts on its effectiveness against COVID-19.
Despite being more contagious than the first coronavirus variant, the new COVID-19 strain does not cause more severe illness or a higher death rate according to a major study.